Michael Byrne
Medical Director, Cellular Therapy OneOncology
Dr. Byrne is a malignant hematologist at Tennessee Oncology. He has led the successful launch of Tennessee Oncology’s cellular therapy program that has expanded access for Tennessee cancer patients to an advanced cellular therapy, known as CAR-T cell therapy. Tennessee Oncology is one of the first practices to deliver CAR-T cell therapy in the community setting.
